Our Audience
Our audience is made up of the teams that buy from suppliers like you. They work in process and analytical development, formulation, quality, supply chain, and regulatory affairs, developing and manufacturing prophylactic and therapeutic vaccines across platforms, from mRNA and viral vectors to recombinant proteins, VLPs, and conjugates. They register with BioInsights for practical answers to the problems your products and services solve.
We put your content in front of them on the topics they already come to us for. Our editors are subject specialists who work with leading experts every day, and they shape your material into the formats these readers use.
Matched to the problem you solve: coverage includes improving mRNA and saRNA stability to move beyond the ultra-cold chain, LNP and adjuvant formulation, scalable and platform-based manufacturing for rapid pandemic response, potency assays and impurity control, the role of AI in process development, and delivery strategies for cancer and other therapeutic vaccines. You reach the readers working on the problem your product addresses.
Targeted by topic, not just job title: every reader registers against at least one specific topic. You choose the problem area, and we reach the people working on it.
The credibility of an expert-led platform: the journal is shaped by an advisory board that includes directors of academic vaccine development centres, regulatory scientists from the FDA, CMC and regulatory leaders at global vaccine manufacturers, and clinical investigators running vaccine trials. Your content carries the BioInsights name.
Attention you can see: a median of 254 registrations per webinar and 46 minutes average viewing time. Registrations and performance are reported to you.
.png)